These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21928410)
41. Survival differences between organ preservation surgery and definitive radiotherapy in early supraglottic squamous cell carcinoma. Arshad H; Jayaprakash V; Gupta V; Cohan DM; Ambujakshan D; Rigual NR; Singh AK; Hicks WL Otolaryngol Head Neck Surg; 2014 Feb; 150(2):237-44. PubMed ID: 24255085 [TBL] [Abstract][Full Text] [Related]
42. Epidermoid carcinoma of the mouth and pharynx at Memorial Sloan-Kettering Cancer Center, 1965 to 1969. Farr HW; Goldfarb PM; Farr CM Am J Surg; 1980 Oct; 140(4):563-7. PubMed ID: 7425241 [TBL] [Abstract][Full Text] [Related]
43. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy. León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494 [TBL] [Abstract][Full Text] [Related]
44. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis. Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858 [TBL] [Abstract][Full Text] [Related]
45. Long-term regional control and survival in patients with "low-risk," early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness. Ganly I; Goldstein D; Carlson DL; Patel SG; O'Sullivan B; Lee N; Gullane P; Shah JP Cancer; 2013 Mar; 119(6):1168-76. PubMed ID: 23184439 [TBL] [Abstract][Full Text] [Related]
46. Clinical and pathologic predictors of survival in patients with squamous cell carcinoma of the hypopharynx after surgical treatment. Chu PY; Li WY; Chang SY Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):201-6. PubMed ID: 18444480 [TBL] [Abstract][Full Text] [Related]
47. Salvage surgery for recurrent larynx cancer. Mimica X; Hanson M; Patel SG; McGill M; McBride S; Lee N; Dunn LA; Cracchiolo JR; Shah JP; Wong RJ; Ganly I; Cohen MA Head Neck; 2019 Nov; 41(11):3906-3915. PubMed ID: 31433540 [TBL] [Abstract][Full Text] [Related]
48. [Outcome of neck dissection for 154 cN0/cN1 patients with squamous cell carcinoma of hypopharynx and prognostic analysis]. Tao L; Zhou L; Wu HT; Zhang M; Li XM; Chen XL; Li C; Xie M; Cheng L; Zhang D Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):272-279. PubMed ID: 30991777 [No Abstract] [Full Text] [Related]
49. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases. Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539 [TBL] [Abstract][Full Text] [Related]
50. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site. Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434 [TBL] [Abstract][Full Text] [Related]
51. Thirty-year experience with 457 radical neck dissections in cancer of the mouth, pharynx, and larynx. Khafif RA; Gelbfish GA; Attie JN; Tepper P; Zingale R Am J Surg; 1989 Oct; 158(4):303-7; discussion 308. PubMed ID: 2802031 [TBL] [Abstract][Full Text] [Related]
52. Feasibility of Salvage Selective Neck Dissection after Primary Irradiation of Pharyngeal and Laryngeal Carcinoma. Mat Lazim N; Abdullah K; Karakullukcu B; Tan IB ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):10-18. PubMed ID: 29428959 [TBL] [Abstract][Full Text] [Related]
53. Management of the "violated neck" in the era of chemoradiation. Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776 [TBL] [Abstract][Full Text] [Related]
54. Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease? Da Mosto MC; Lupato V; Romeo S; Spinato G; Addonisio G; Baggio V; Gava A; Boscolo-Rizzo P Ann Surg Oncol; 2013 Jan; 20(1):250-6. PubMed ID: 22836557 [TBL] [Abstract][Full Text] [Related]
55. Persistent neck disease after chemoradiation for head and neck squamous cell carcinoma. Sanders JG; Smith KG; Jameson MB; de Groot C; White J J Laryngol Otol; 2012 Nov; 126(11):1121-6. PubMed ID: 22989730 [TBL] [Abstract][Full Text] [Related]
56. Management of the N0 neck in patients with laryngeal squamous cell carcinoma. Shi Y; Zhou L; Tao L; Zhang M; Chen XL; Li C; Gong HL Acta Otolaryngol; 2019 Oct; 139(10):908-912. PubMed ID: 31343387 [No Abstract] [Full Text] [Related]
57. Is lymph-node ratio a superior predictor than lymph node status for recurrence-free and overall survival in patients with head and neck squamous cell carcinoma? Reinisch S; Kruse A; Bredell M; Lübbers HT; Gander T; Lanzer M Ann Surg Oncol; 2014 Jun; 21(6):1912-8. PubMed ID: 24652351 [TBL] [Abstract][Full Text] [Related]